The 2019 new coronavirus (SARS-CoV-2) is a novel respiratory virus which has increasingly spread all over the world. Although the predominant clinical presentation is represented by respiratory symptoms, neurological manifestation of SARS-CoV-2 is being increasingly recognized. In the present report, we present a case of post SARS-CoV-2 autoimmune encephalitis associated with a new-onset refractory status epilepticus (NORSE).
New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report
Dono F.;Carrarini C.;Russo M.;De Angelis M. V.;Anzellotti F.;Onofrj M.;Bonanni L.
2021-01-01
Abstract
The 2019 new coronavirus (SARS-CoV-2) is a novel respiratory virus which has increasingly spread all over the world. Although the predominant clinical presentation is represented by respiratory symptoms, neurological manifestation of SARS-CoV-2 is being increasingly recognized. In the present report, we present a case of post SARS-CoV-2 autoimmune encephalitis associated with a new-onset refractory status epilepticus (NORSE).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dono_Neurological Science_2021.pdf
Solo gestori archivio
Descrizione: Articolo principale
Tipologia:
PDF editoriale
Dimensione
332.9 kB
Formato
Adobe PDF
|
332.9 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
